Wolverine Asset Management LLC Novo Cure LTD Put Options Transaction History

Wolverine Asset Management LLC

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 May 13, 2024	SELL	$12.42 - $17.29 $122,958 - $171,171	-9,900 Reduced 95.19%	500 $7,000
Q2 2023 Aug 07, 2023	BUY	$40.29 - $82.51 $56,406 - $115,514	1,400 Added 15.56%	10,400 $431,000
Q1 2023 May 08, 2023	SELL	$56.44 - $118.81 $7.94 Million - $16.7 Million	-140,600 Reduced 93.98%	9,000 $541,000
Q4 2022 Feb 01, 2023	BUY	$63.98 - $85.37 $422,268 - $563,442	6,600 Added 4.62%	149,600 $11 Million
Q3 2022 Nov 10, 2022	BUY	$67.99 - $89.57 $108,783 - $143,312	1,600 Added 1.13%	143,000 $10.9 Million
Q2 2022 Aug 03, 2022	SELL	$56.6 - $89.9 $4.2 Million - $6.67 Million	-74,200 Reduced 34.42%	141,400 $9.83 Million
Q1 2022 May 04, 2022	BUY	$60.15 - $84.52 $13 Million - $18.2 Million	215,600 New	215,600 $17.9 Million

262

77M

1.17M

318K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $2.88B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Wolverine Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Asset Management LLC with notifications on news.